Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Physics and Imaging in Radiation Oncology|July 8, 2022
Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapyPeter Mbanu, Mark P Saunders, Hitesh Mistry, et al.Future Oncology (London, England)|July 28, 2020
Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progressionTheodora Germetaki, Camille Nicholls, Richard A Adams, et al.British Journal of Cancer|August 21, 2024
Pre-treatment magnetic resonance imaging in anal cancer: large-scale evaluation of mrT, mrN and novel staging parametersHema Sekhar, Rohit Kochhar, Bernadette Carrington, et al.British Journal of Cancer|January 15, 2020
Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014)Hema Sekhar, Lee Malcomson, Rohit Kochhar, et al.The Lancet. Gastroenterology & Hepatology|December 4, 2018
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensusRebecca Fish, Caroline Sanders, Richard Adams, et al.Journal of Clinical Gastroenterology|October 25, 2013
Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancerLeila Khoja, Gireesh Kumaran, Ying Kiat Zee, et al.Clinical Colorectal Cancer|February 15, 2015
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal CancerMatthew G Krebs, Andrew G Renehan, Alison Backen, et al.The Lancet. Gastroenterology & Hepatology|December 5, 2022
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 studyThierry André, Alfredo Falcone, Yaroslav Shparyk, et al.The Lancet. Oncology|December 27, 2015
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysisAndrew G Renehan, Lee Malcomson, Richard Emsley, et al.Clinical and Experimental Medicine|January 21, 2026
Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocolEleftherios Christodoulis, Panagiotis J Vlachostergios, Jacqueline Connell, et al.Pageof 6